AzTrials
AzTrials

Prosthesis UserNCT07075198

Caesar Foot Take-Home Validation Testing

A study testing Caesar Foot in people with Prosthesis User and Lower Limb Amputation Below Knee (Injury), run by Liberating Technologies, Inc. at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The rationale for this study is to conduct a take-home clinical trial to evaluate the impact of the bimodal Caesar foot in a real-world environment. Participants will take the device home and use it throughout their daily life for two months. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Caesar Foot
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
1 siteUnited States
Study dates
Oct 2025to Aug 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Have transtibial limb absence of one or both limbs
  • Express interest in running, but do not currently have a running blade (as determined by self-report)
  • Are at least 18 years of age
  • Are at least six months post amputation
  • Are classified as K3 or K4 ambulator status as determined by a certified prosthetist
  • Have an AMP score of at least 37
Show all 10Show fewer
  • Are capable of running safely as determined by a certified prosthetist's clinical judgement
  • Have a well-fitting socket as determined by a certified prosthetist
  • Have adequate clearance between distal end of the residual limb and ground for the Caesar foot
  • Meets the foot size and weight class of one of the available Caesar prototypes

Who cannot join

  • Present or sustained injuries to residual limb or contralateral leg affecting functional ability
  • Non-English speaking participants will be excluded from this study due to limited access to interpreter services. These services would be needed for several visits, including training to learn how to use the device safely, along with requested verbal feedback from the participant to evaluate the design and usability of the system.
  • Using a prosthetic foot that an individual is unfamiliar with for higher activity tasks may increase the risk of falling. Therefore, pregnant women should not participate in the study and will be screened by self-disclosure.
  • Individuals can be excluded at the discretion of the investigator for other unforeseen disqualifying criteria (such as specific cognitive issues, etc.).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • Hanger Clinic

    Austin, Texas, 78758

    Shane Wurdeman, PhD, 402-290-8051, swurdeman@hanger.com

    Todd Castleberry, (512) 284-1337, tcastleberry@hanger.com

    Recruiting

Other trials in United States

About this study

The rationale for this study is to conduct a take-home clinical trial to evaluate the impact of the bimodal Caesar foot in a real-world environment. Participants will take the device home and use it throughout their daily life for two months. A one-month baseline period, using their usual foot, will be completed both before and after the two-month period with the Caesar foot condition. Self-report surveys and performance-based measures will be collected in the clinic at the end of each condition. The intent of this study is to determine the Caesar foot's feasibility in a real-world environment. Data will be collected to understand impact to the user's daily life and physical activity through outcomes and participant feedback. The feedback obtained during this study will be essential to informing the design intended for commercialization.

Read the detailed description

In this study, the investigators will administer a suite of performance-based and self-report measures to assess demonstrated and perceived differences between the foot conditions. The primary measure for this study is the Prosthetic Limb Users Survey of Mobility (PLUS-M). The investigators hypothesize that the participants will have greater mobility as reported by the PLUS-M in the Caesar foot as compared to their usual walking foot.

There are many aspects of mobility and activity that may not be captured by a single assessment. Therefore, the investigators will examine additional exploratory self-report measures after each condition during this pilot study, such as the PROMIS-Fatigue, PROMIS- Ability to Participate in Social Roles and Activities (PROMIS-APSRA), PLUS-Falls (PLUS-F), Trinity Amputation and Prosthesis Experience Scale - Revised (TAPES-R), EQ-5D, and custom surveys to further understand the participant's experiences and preferences with the Caesar foot. Surveys will be distributed on a HIPAA compliant platform, such as MS Forms, which can be completed on the clinic's laptop/tablet. Paper formats of the surveys may be distributed if issues arise with the online platform (e.g., internet outage).

The investigators will also conduct and collect performance-based measures from each participant, such as the 10-Meter Walk Test (10MWT), self-selected comfortable and fast gait speeds, comfortable running speed, and timed ¼ mile run. These measures are exploratory as well. The investigators will assess running effort objectively with the maximum heart rate (HRmax) during the ¼ mile run and subjectively using the Borg Rating of Perceived Exertion (RPE). During each 1-month take-home period, the investigators will measure participants' daily step count and track any falls that may occur.

In addition to wearing the activity monitor during the take-home periods, they will also be asked to participate in periodic calls with study team members to check in and report on any falls, issues they may be experiencing, and/or ask questions they may have about the study. These periodic calls will continue throughout the duration of the study.

As a pilot study, the goal of these measures is to better understand the impact of the Caesar foot on different aspects of a user's life and incorporate feedback into future designs.

The investigators plan to implement a pilot longitudinal comparative effectiveness study with an ABA study design, where A1 is the first control condition with the participant's usual prosthetic foot, B is the experimental condition with the Caesar Foot, and A2 is the second control condition with the participant's usual prosthetic foot. For each condition, the participant will use their usual prosthetic socket, and a certified prosthetist will set up and align them on the foot of interest. They will be provided time for acclimation to each prosthetic foot prior to Condition B and Condition A2 as they will have swapped to a foot that they were not using previously. Activity monitors will then be added to the prosthesis and the participant will wear the foot at home for one month.

All participants for this study will be individuals who desire to participate in running/jogging but do not currently have a running prosthesis, as determined by self-report. Eligible participants will be individuals who are at least 18 years of age and have transtibial limb absence of one or both limbs, a K-level of K3 or K4, the required foot size, weight, and limb clearance for one of the available Caesar prototypes, and have a well-fitting socket as determined by a certified prosthetist.

For the first month of the experimental condition (Condition B), the participant will wear the Caesar foot at home to acclimate to the foot and participate in a running training program. Training is necessary to fully utilize and maximize the performance with any prosthetic component. Therefore, the investigators leveraged the expertise of the investigators' collaborator, Alicia White, PT, DPT, ATC to implement a running training program. Dr. White developed the "Return to Run" program at the Department of Defense's Center for the Intrepid (CFI) to teach individuals with lower limb amputations how to run on a running blade prosthesis. She will train physical therapists at Hanger to teach study participants how to run on a prosthesis. Participants will attend at least two, but up to twelve, 1-hour training sessions.

The training will be designed to teach basic running mechanics that are agnostic of the foot used, as well as running blade-specific skills. The training will be tailored to the starting abilities of each participant and progress at an appropriate pace for each individual until they are competent at running (i.e., their running trainer deems they can safely run on the foot and the participant is comfortable doing so).

At a minimum, each participant will receive one training session to learn how to safely and properly run in the Caesar foot and a second session to demonstrate their competency in running with the foot. The participant will continue training until they show competence (as determined by their trainer) or until they receive twelve training sessions, whichever comes first. Because the participants will be new to running with a running foot, the training will be provided during the first month of condition B so participants can safely run on and acclimate to the Caesar Foot.

Participation in this study will consist of 5 site visits and about 4 months of at-home wear of the participant's usual foot and Caesar foot, as well as running training, and performance-based and self-report assessments throughout each condition. Participants may be asked to come in for additional visits for various reasons, such as technical issues with the device, running out of time in the visit before completing the outlined tasks/measures, etc.

Shortly after Visit 5, a study team member will conduct a final call with the participant to go over any other falls that may have occurred before Visit 5, clarify any missing data from surveys, and conduct the exit interview and preference survey. After this call, they will have completed their participation in study.

Being tested
Caesar Foot
Medical subject headings
Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Caesar FootDevice

    The investigators developed a bimodal, passive mechanical prosthetic foot called the Caesar Foot. The Caesar Foot has two modes: one optimized for walking, and one optimized for higher-energy activities like running. It has a switching device that was designed such that when it switches modes, it inherently accounts for the alignment and stiffness differences between walking and running feet (such as the longer length, higher stiffness, and different ground contact points required for running feet). Therefore, it should be largely comparable to a daily use prosthesis / walking foot when in walking mode, and an running specific prosthesis / running blade when in running mode. This foot is attached and aligned to the user's usual prosthetic socket.

Study groups in NCT07075198
Study groupRoleWhat they receive
Usual Prosthesis Pre-Experimental Condition (Baseline)No interventionThe participant wears their usual prosthetic foot for 1 month before the experimental condition to collect baseline data.
Caesar FootExperimentalThe participant wears the Caesar Foot at home for about 2 months.
Receives: Device: Caesar Foot
Usual Prosthesis Post-Experimental ConditionNo interventionThe participant wears their usual prosthetic foot for 1 month after completing the experimental condition and after receiving running training.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prosthetic Limb Users Survey of Mobility (PLUS-M)

    The version of the PLUS-M being administered consists of 22 questions. Each question asks about their ability to ambulate in certain instances and at certain speeds, and is scored on a scale of 1 (unable to do) to 5 (without any difficulty). A higher score indicates a better outcome.

    This survey will be given at the end of each study condition. Since the first month of the Caesar condition will be for training and acclimation, the PLUS-M will be given after the second month that the participant is in the experimental condition.

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2025
  2. Study startOct 2025 (estimated)
  3. Primary completionAug 2026 (estimated)
  4. Study completionAug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
18 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07075198
Sponsor's protocol ID
13875
Other IDs
1R44HD113432-01
Status last verified
Oct 2025
First submitted
24 Jun 2025
Last updated
14 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Caesar Foot in people with Prosthesis User and Lower Limb Amputation Below Knee (Injury), run by Liberating Technologies, Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 14 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jennifer Johansson (774-233-0874, jen.johansson@liberatingtech.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prosthetic Limb Users Survey of Mobility (PLUS-M) (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in